BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 71 filers reported holding BIODELIVERY SCIENCES INTL IN in Q4 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $87,000 | -32.0% | 28,204 | -20.3% | 0.00% | – |
Q3 2021 | $128,000 | +48.8% | 35,397 | +47.5% | 0.00% | – |
Q2 2021 | $86,000 | -75.6% | 23,995 | -73.4% | 0.00% | – |
Q1 2021 | $353,000 | +161.5% | 90,079 | +180.3% | 0.00% | – |
Q4 2020 | $135,000 | +92.9% | 32,133 | +71.8% | 0.00% | – |
Q3 2020 | $70,000 | -63.9% | 18,704 | -57.9% | 0.00% | – |
Q2 2020 | $194,000 | +21.2% | 44,394 | +5.5% | 0.00% | – |
Q1 2020 | $160,000 | -8.6% | 42,065 | +52.0% | 0.00% | – |
Q4 2019 | $175,000 | +872.2% | 27,683 | +568.0% | 0.00% | – |
Q3 2019 | $18,000 | -83.6% | 4,144 | -82.4% | 0.00% | – |
Q2 2019 | $110,000 | -81.6% | 23,547 | -79.1% | 0.00% | -100.0% |
Q1 2019 | $597,000 | +14825.0% | 112,676 | +11167.6% | 0.00% | – |
Q4 2018 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
Q3 2018 | $3,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2018 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2018 | $2,000 | -33.3% | 1,000 | 0.0% | 0.00% | – |
Q4 2017 | $3,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2017 | $3,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2017 | $3,000 | +50.0% | 1,000 | -0.5% | 0.00% | – |
Q1 2017 | $2,000 | 0.0% | 1,005 | 0.0% | 0.00% | – |
Q4 2016 | $2,000 | -33.3% | 1,005 | 0.0% | 0.00% | – |
Q3 2016 | $3,000 | -40.0% | 1,005 | -51.8% | 0.00% | – |
Q2 2016 | $5,000 | -96.1% | 2,086 | -94.7% | 0.00% | – |
Q1 2016 | $128,000 | +113.3% | 39,689 | +215.2% | 0.00% | – |
Q4 2015 | $60,000 | -15.5% | 12,592 | -0.5% | 0.00% | – |
Q3 2015 | $71,000 | -36.0% | 12,657 | -8.3% | 0.00% | – |
Q2 2015 | $111,000 | -22.9% | 13,802 | -0.3% | 0.00% | – |
Q1 2015 | $144,000 | +9.1% | 13,838 | +25.5% | 0.00% | – |
Q4 2014 | $132,000 | +80.8% | 11,027 | +158.9% | 0.00% | – |
Q3 2014 | $73,000 | +43.1% | 4,259 | +1.6% | 0.00% | – |
Q2 2014 | $51,000 | -23.9% | 4,192 | -47.0% | 0.00% | – |
Q1 2014 | $67,000 | -1.5% | 7,911 | -31.3% | 0.00% | – |
Q4 2013 | $68,000 | +6700.0% | 11,523 | +8250.0% | 0.00% | – |
Q3 2013 | $1,000 | – | 138 | +253.8% | 0.00% | – |
Q2 2013 | $0 | – | 39 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 1,575,000 | $6,615,000 | 4.38% |
1492 Capital Management LLC | 790,863 | $3,322,000 | 1.91% |
Rubric Capital Management LP | 3,516,124 | $14,768,000 | 1.08% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $40,026,000 | 0.79% |
Zebra Capital Management LLC | 144,241 | $606,000 | 0.77% |
KNOTT DAVID M | 370,230 | $1,555,000 | 0.70% |
Nantahala Capital Management | 5,123,671 | $21,519,000 | 0.67% |
SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,593,893 | $15,094,000 | 0.66% |
EMC Capital Management | 98,933 | $416,000 | 0.32% |
ALGERT GLOBAL LLC | 175,170 | $736,000 | 0.21% |